Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Methods × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 3 Skin Carcinoma 2 Pain 2 Neoplasms 2 Lung Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Smoking 1 Smoking Cessation 1 Smoking 1 Sepsis 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Frailty 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Cigarette Smoking 1 Chemotherapy-Induced Peripheral Neuropathy 1 Behavior, Addictive 1 Alzheimer Disease 1 Agnosia 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡